AGP Picks
View all

The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on May 22, 2026

Hudson Capital Advisors Announces Strategic Finance Engagement with Krytheon
WeShip Express Announces Integration with ShipStation to Streamline Compliant Wine Shipping
Confinaid Outlines Vision for Preventive Compliance in the AI Era
INKBIRD Lowers Prices on Grilling and Smart Home Devices for Father’s Day
EaseOS by StoreEase Now Fully Integrated with Self Storage Manager (SSM)
Google Kubernetes Engine (GKE) boosted AI inferencing compared to Amazon EKS
2Mynds Launches Mental Performance Course for Parents of High-Performing Juniors
Neural4D Launches Text to Image and Text to Video, Completing an End-to-End AI Creative Pipeline
Alessa Therapeutics Appoints Dr. Peter Carroll and Dr. Neal Shore to Lead Clinical Advisory Board
Calidi Biotherapeutics Provides Required NYSE American Disclosure
Squirrel Ai Learning’s Derek Li Unveils New IEEE AI Education Standards Working Group at ASU+GSV Summit
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
SCYNEXIS Announces One-for-Eight Reverse Stock Split
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars
Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
XTL Announces Receipt of Staff Delist Determination from Nasdaq
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The California STEM Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.